Heart tumor successfully removed during fetal surgery

After undergoing prenatal heart surgery at just 24 weeks of gestation while still in his mother’s womb, Tucker Roussin, now 3 years old, is alive and doing well.

He is the first successful survivor of fetal heart surgery to remove an intrapericardial teratoma, a rare and life-threatening heart tumor.

Roussin’s case and findings from his surgery have been published online in the American Journal of Obstetrics and Gynecology, by Jack Rychik, MD, director of the Fetal Heart Program at the Children’s Hospital of Philadelphia (CHOP) and Nahla Khalek, MD, from the Center for Fetal Diagnosis and Treatment at CHOP.

To read more about the surgery and the findings of the study, follow the link below:

Katherine Davis,

Senior Writer

As a Senior Writer for TriMed Media Group, Katherine primarily focuses on producing news stories, Q&As and features for Cardiovascular Business. She reports on several facets of the cardiology industry, including emerging technology, new clinical trials and findings, and quality initiatives among providers. She is based out of TriMed's Chicago office and holds a bachelor's degree in journalism from Columbia College Chicago. Her work has appeared in Modern Healthcare, Crain's Chicago Business and The Detroit News. She joined TriMed in 2016.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.